10.25GBP0.00%Mkt Cap: 16.45M $P/E: —1d ago
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap16.45M $
Enterprise Value15.12M $
Revenue (TTM)2.05M $
Gross Profit551.52K $
Net Income (TTM)-2.20M $
Revenue/Share0.0192 USD
Last Price10.25 GBP
Fiscal Year EndMar 2025
MR QuarterSep 2025
Employees24
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.25
PEG—
EV/EBITDA-8.43
EV/Revenue7.38
P/S7.94
P/B16.87
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.000049% of range21.00
52W High21.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin21.88%
Oper. Margin-64.44%
EBITDA Margin-87.59%
Profit Margin-87.18%
ROE-256.05%
ROA-129.48%
Growth
Revenue Growth-30.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.75M $
CapEx (TTM)12.83K $
FCF Margin-48.68%
FCF Yield-6.06%
Net Debt174.43K $
Net Debt/EBITDA-0.10
Balance Sheet
Debt/Equity0.03
Current Ratio1.80
Quick Ratio1.45
Book Value/Sh0.0060 GBP
Cash/Share0.0020 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.125.16M
Float98.15M
Insiders12.37%
Institutions26.36%
Technical
SMA 5011.03 (-7.0%)
SMA 20013.05 (-21.5%)
Beta1.22
S&P 52W Chg18.16%
Avg Vol (30d)275.83K
Avg Vol (10d)275.90K
Technical Indicators
RSI (14)42.5
MACD-0.2076
MACD Signal-0.2423
MACD Hist.+0.0347
BB Upper11.15 GBP
BB Middle10.45 GBP
BB Lower9.741 GBP
BB Width13.51%
ATR (14)1.018 GBP
Vol Ratio (20d)0.88x